OPKO Health
OPK
#5857
Rank
A$1.60 B
Marketcap
A$2.02
Share price
-0.74%
Change (1 day)
-17.12%
Change (1 year)

OPKO Health (OPK) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.59 Billion

According to OPKO Health 's latest financial reports the company's total debt is A$0.59 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

OPKO Health - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.81 B69.2%
2023-12-31A$0.47 B6.75%
2022-12-31A$0.44 B27.78%
2021-12-31A$0.35 B-8.28%
2020-12-31A$0.38 B-15.11%
2019-12-31A$0.45 B48.94%
2018-12-31A$0.30 B49.73%
2017-12-31A$0.20 B38.33%
2016-12-31A$0.14 B-28.83%
2015-12-31A$0.20 B14.17%
2014-12-31A$0.18 B-29.49%
2013-12-31A$0.25 B1070.1%
2012-12-31A$21.82 M155.5%
2011-12-31A$8.54 M-40.94%
2010-12-31A$14.46 M-33.93%
2009-12-31A$21.88 M11.98%
2008-12-31A$19.54 M20.05%
2007-12-31A$16.28 M
2002-12-31A$0.35 M-9.42%
2001-12-31A$0.39 M77.04%
2000-12-31A$0.22 M8.82%
1999-12-31A$0.2 M-37.1%
1998-12-31A$0.32 M112.8%
1997-12-31A$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$68.94 B 11,481.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B 3,172.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$4.07 B 584.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.70 B 4,217.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
A$1.96 B 230.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.84 B 12,808.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$9.83 B 1,551.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.31 B-47.50%๐Ÿ‡บ๐Ÿ‡ธ USA